SHEA GUIDELINES Bundle (free trial)

Duration of Contact Precautions

SHEA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: http://eguideline.guidelinecentral.com/i/962358

Contents of this Issue

Navigation

Page 1 of 5

Key Points ➤ This expert guidance document provides recommendations regarding discontinuation of contact precautions (CP) at the individual patient level in acute-care hospitals employing CP for 1 or more of the following organisms: methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), Clostridium difficile (CDI), and multidrug-resistant Enterobacteriaceae (MDR-E), including carbapenem- resistant Enterobacteriaceae (CRE) and extended-spectrum β-lactamase (ESBL)–producing organisms. ➤ Recommendations herein are based on synthesis of limited evidence, theoretical rationale, current practices, practical considerations, the opinion of the writing group, consideration of potential harms, and a survey of 134 institutions within the SHEA Research Network, 26% of which are outside the United States and Canada.

Articles in this issue

Archives of this issue

view archives of SHEA GUIDELINES Bundle (free trial) - Duration of Contact Precautions